Measured in a serum-free cell proliferation assay using MCF‑7 human breast cancer cells. Karey, K.P. et al. (1988) Cancer Research 48:4083. The ED50 for this effect is 0.6-3 ng/mL.
Source
E. coli-derived rat IGF-I/IGF-1 protein
MHHHHHHN
Rat IGF-I/IGF-1 (Gly23-Ala92) Accession # AAA41386
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Note
<0.10 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Bioactivity
Theoretical MW
8.8 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Publications
Read Publications using 4326-RG in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS.
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile PBS.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Rat IGF-I/IGF-1 Protein, CF
IBP1
IGF1
IGF-1
IGF1A
IGFI
IGF-I
IGF-IA
IGF-IB
insulin-like growth factor 1 (somatomedin C)
insulin-like growth factor 1
insulin-like growth factor I
insulin-like growth factor IA
insulin-like growth factor IB
Mechano growth factor
MGF
Somatomedin A
Somatomedin C
somatomedin-C
Background
Insulin-like growth factor I (IGF-I or IGF-1), also known as somatomedin C, is the dominant effector of growth hormone and is structurally homologous to proinsulin. Rat IGF-I/IGF-1 is synthesized as four precursor isoforms with alternate N- and C-terminal propeptides (1). These isoforms are differentially expressed by various tissues (1). The 7.6 kDa mature IGF-I/IGF-1 is identical between isoforms and is generated by proteolytic removal of the N- and C-terminal regions. Mature rat IGF-I/IGF-1 shares 96% and 99% aa sequence identity with human and mouse IGF-I/IGF-1, respectively (2, 3), and exhibits cross-species activity. It shares 61% aa sequence identity with mature rat IGF-II/IGF-2. Circulating IGF-I/IGF-1 is produced by hepatocytes, while local IGF-I/IGF-1 is produced by many other tissues in which it has paracrine effects (1). IGF-I/IGF-1 induces the proliferation, migration, and differentiation of a wide variety of cell types during development and postnatally (4). IGF-I/IGF-1 regulates glucose and fatty acid metabolism, steroid hormone activity, and cartilage and bone metabolism (5 - 8). It plays an important role in muscle regeneration and tumor progression (1, 9). IGF-I/IGF-1 binds IGF-I R, IGF-II R, and the insulin receptor, although its effects are mediated primarily by IGF-I R (10). Heterodimers of insulin receptor/IGF-I R also exist and respond to IGF-I/IGF-1 but not to insulin stimulation (11). IGF-I/IGF-1 association with IGF binding proteins increases its plasma half-life and modulates its interactions with receptors (12).
Philippou, A. et al. (2007) In Vivo 21:45.
Roberts, Jr., C.T. et al. (1987) Mol. Endocrinol. 1:243.
Shimatsu, A. and P. Rotwein (1987) J. Biol. Chem. 262:7894.
Guvakova, M.A. (2007) Int. J. Biochem. Cell Biol. 39:890.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Rat IGF-I/IGF-1 Protein, CF and receive a gift card or discount.